Cargando…
Armeniaspirol A: a novel anti‐Helicobacter pylori agent
Antibiotic resistance in Helicobacter pylori has been growing worldwide with current treatment regimens. Development of new compounds for treatment of H. pylori infections is urgently required to achieve a successful eradication therapy in the future. Armeniaspirols, a novel class of natural product...
Autores principales: | Jia, Jia, Zhang, Chongwen, Liu, Yaqi, Huang, Yanqiang, Bai, Yuefan, Hang, Xudong, Zeng, Liping, Zhu, Dongqing, Bi, Hongkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867979/ https://www.ncbi.nlm.nih.gov/pubmed/33780131 http://dx.doi.org/10.1111/1751-7915.13807 |
Ejemplares similares
-
Total synthesis and mechanism of action of the antibiotic armeniaspirol A
por: Arisetti, Nanaji, et al.
Publicado: (2021) -
Daphnetin: A Novel Anti-Helicobacter pylori Agent
por: Wang, Genzhu, et al.
Publicado: (2019) -
Killing of Staphylococcus aureus persisters by a multitarget natural product chrysomycin A
por: Jia, Jia, et al.
Publicado: (2023) -
Enhancing armeniaspirols production through multi-level engineering of a native Streptomyces producer
por: Heng, Elena, et al.
Publicado: (2023) -
Helicobacter pylori FabX contains a [4Fe-4S] cluster essential for unsaturated fatty acid synthesis
por: Zhou, Jiashen, et al.
Publicado: (2021)